Oxford BioDynamics (Oxford BioDynamics) Earnings per Share (Diluted) : $-0.09 (TTM As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Oxford BioDynamics Earnings per Share (Diluted)?

Oxford BioDynamics's Earnings per Share (Diluted) for the six months ended in Sep. 2023 was $-0.05. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.09.

Oxford BioDynamics's EPS (Basic) for the six months ended in Sep. 2023 was $-0.05. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.09.

Oxford BioDynamics's EPS without NRI for the six months ended in Sep. 2023 was $-0.04. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.08.

During the past 3 years, the average EPS without NRIGrowth Rate was -12.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was -28.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was -7.10% per year.

During the past 11 years, Oxford BioDynamics's highest 3-Year average EPS without NRI Growth Rate was 42.20% per year. The lowest was -48.50% per year. And the median was -19.95% per year.

Oxford BioDynamics Earnings per Share (Diluted) Historical Data

The historical data trend for Oxford BioDynamics's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Earnings per Share (Diluted) Chart

Oxford BioDynamics Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Earnings per Share (Diluted)

Get a 7-Day Free Trial

-0.04

-0.06

-0.10

-0.08

-0.09

Oxford BioDynamics Semi-Annual Data
	Sep13	Sep14	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Earnings per Share (Diluted)	Get a 7-Day Free Trial														-0.05	-0.04	-0.04	-0.04	-0.05

Competitive Comparison of Oxford BioDynamics's Earnings per Share (Diluted)

For the Biotechnology subindustry, Oxford BioDynamics's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford BioDynamics's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioDynamics's PE Ratio distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's PE Ratio falls into.

Oxford BioDynamics Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Oxford BioDynamics's Earnings Per Share (Diluted) for the fiscal year that ended in Sep. 2023 is calculated as

Diluted Earnings Per Share (A: Sep. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-13.399	-	0)	/	147.482
	=	-0.09

Oxford BioDynamics's Earnings Per Share (Diluted) for the quarter that ended in Sep. 2023 is calculated as

Diluted Earnings Per Share (Q: Sep. 2023 )	=	(Net Income	-	Preferred Dividends	/	Shares Outstanding (Diluted Average)
	=	(-7.9	-	0)	/	155.863
	=	-0.05

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.09

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

Oxford BioDynamics (OTCPK:OXBOF) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Oxford BioDynamics Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioDynamics (Oxford BioDynamics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (OTCPK:OXBOF) » Definitions » Earnings per Share (Diluted)

Comparable Companies

Traded in Other Exchanges

OBD:UK

Address

Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB

Website

https://www.oxfordbiodynamics.com

Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.